Matthew Lucas
About Matthew Lucas
Matthew Lucas is the Director of Medical Strategy for Hypertrophic Cardiomyopathy at Bristol Myers Squibb in Princeton, New Jersey. He has extensive experience in medical affairs and strategy, having previously held various leadership roles at Merck.
Current Role at Bristol Myers Squibb
Matthew Lucas is currently the Director of Medical Strategy for Hypertrophic Cardiomyopathy at Bristol Myers Squibb, based in Princeton, New Jersey. In this role, he oversees strategic decisions on the best activities and right channels to address the regional education gap in hypertrophic cardiomyopathy. He collaborates with the Worldwide Medical and Clinical Development teams to pursue a strategic vision for the product lifecycle within this disease area. Additionally, he supports regional insight-gathering activities to better understand shared-decision practices in the medical field.
Previous Roles at Bristol Myers Squibb
Before his current position, Matthew Lucas served as the Head of US Field Medical Capability at Bristol Myers Squibb from 2019 to 2021 in Princeton, New Jersey. In this role, he was responsible for aligning field medical strategies with business objectives, leading the US Medical matrix teams, and setting medical strategies and objectives, including ISR strategy, communication, publication, and Field Medical activities.
Career at Merck
Matthew Lucas had a distinguished career at Merck, holding various positions over nearly two decades. From 2017 to 2019, he was the Director of Medical Affairs (Strategy Lead, Women’s Health). From 2015 to 2017, he was the Director of Medical Affairs (Strategy Lead, CV/Metabolic). Prior to that, he served as the Director of Medical Affairs (Team Leader, CV/Metabolic) from 2013 to 2015. Earlier roles included Health Science Team Leader and Promotion Manager. His career at Merck began in 1995 as a Health Management Coordinator in the Miami/Fort Lauderdale Area.
Educational Background
Matthew Lucas holds a Doctor of Pharmacy (PharmD) degree from the University of Florida, where he studied Pharmacy from 1987 to 1995. He also attended Coombabah State High in Queensland, Australia for high school in 1986, and LaGrange High School from 1983 to 1987.